Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study. Read more about Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study.
Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases. Read more about Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases.
NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer. Read more about NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer.
PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast cancer: a meta-analysis of published clinical trials. Read more about PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast cancer: a meta-analysis of published clinical trials.
Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview study. Read more about Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview study.
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial. Read more about Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial.
Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study. Read more about Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.
Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans. Read more about Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans.
Distinct employment interference profiles in patients with breast cancer prior to and for 12 months following surgery. Read more about Distinct employment interference profiles in patients with breast cancer prior to and for 12 months following surgery.
Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients. Read more about Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients.
